
Vingose 0.2mg FlashTab
Marketer
Novartis India Ltd
Salt Composition
Voglibose (0.2mg)
Overview Vingose 0.2mg FlashTab
Diabetase 0.2mg FlashTab is a medication prescribed for managing type 2 diabetes. It aids in regulating elevated post-prandial blood glucose. This medication is indicated when dietary modifications and other comparable therapies prove insufficient to control hyperglycemia. Diabetase 0.2mg FlashTab should be administered immediately prior to meals. Dosage frequency is determined by your physician to optimize blood sugar management. Discontinue use only under medical supervision; abrupt cessation may elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Closely monitor blood glucose levels during treatment. Commonly reported side effects include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Diabetase 0.2mg FlashTab alone does not induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose should be used to treat hypoglycemic episodes; sucrose is ineffective in this context. Inform your physician of any pre-existing kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all medications currently being taken to ensure treatment safety. Limit alcohol consumption while using this medicine to minimize the potential for hypoglycemia.
Uses of Vingose 0.2mg FlashTab
Managing Type 2 diabetes
Major Benefits of Vingose 0.2mg FlashTab:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Vingose 0.2mg FlashTab on an empty stomach.
Common Side effects of Vingose 0.2mg FlashTab:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vingose 0.2mg FlashTab:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vingose 0.2mg FlashTab on an empty stomach.
How Vingose 0.2mg FlashTab works:
FlashTab Vingose (0.2mg) is an antidiabetic medication that works by suppressing the activity of intestinal enzymes which digest complex carbohydrates into simple sugars like glucose. This action helps to moderate postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Vingose 0.2mg FlashTab.
PregnancySAFE IF PRESCRIBED
The oral disintegrating tablet Vingose 0.2mg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
FlashTab Vingose 0.2mg is likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with its use.
DrivingSAFE
Driving ability is typically unaffected by Vingose 0.2mg FlashTab.
KidneyCAUTION
Patients with severe kidney impairment should use Vingose 0.2mg FlashTab cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vingose 0.2mg FlashTab cautiously. Dosage modification of Vingose 0.2mg FlashTab might be necessary. Physician consultation is advised.
What if you forget to take Vingose 0.2mg FlashTab :
Omit any missed Vingose 0.2mg FlashTab dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Vingose 0.2mg FlashTab
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
